Products

Inulae Flos Veterinary Grade API for Tablets / Injections / Capsules / Powders / Granules / Premix / Solutions

    • Product Name: Inulae Flos Veterinary Grade API for Tablets / Injections / Capsules / Powders / Granules / Premix / Solutions
    • Alias: INULA-API-VET
    • Einecs: 289-810-0
    • Mininmum Order: 1 g
    • Factroy Site: Yudu County, Ganzhou, Jiangxi, China
    • Price Inquiry: admin@ascent-chem.com
    • Manufacturer: Ascent Petrochem Holdings Co., Limited
    • CONTACT NOW
    Specifications

    HS Code

    127281

    Product Name Inulae Flos Veterinary Grade API
    Application Forms Tablets, Injections, Capsules, Powders, Granules, Premix, Solutions
    Main Ingredient Inulae Flos (flower of Inula helenium)
    Intended Use Veterinary medicine
    Purity ≥98% (varies by supplier specification)
    Appearance Fine yellow-brown powder
    Solubility Partially soluble in water and ethanol
    Storage Conditions Store in a cool, dry place away from direct sunlight
    Shelf Life 24 months when properly stored
    Packaging Sealed aluminum foil bags or fiber drums
    Country Of Origin China (commonly used source)
    Quality Standard Complies with veterinary API regulations
    Active Compounds Mainly sesquiterpene lactones
    Manufacturing Method Extracted from dried Inulae Flos flowers
    Common Administration Oral, injection, premix in feed

    As an accredited Inulae Flos Veterinary Grade API for Tablets / Injections / Capsules / Powders / Granules / Premix / Solutions factory, we enforce strict quality protocols—every batch undergoes rigorous testing to ensure consistent efficacy and safety standards.

    Packing & Storage
    Packing Sealed 25 kg fiber drum with inner double-layer plastic bags, labeled for veterinary use: Inulae Flos API, tablets/injections/capsules/powders/granules/premix/solutions.
    Shipping The Inulae Flos Veterinary Grade API is securely packaged in sealed, moisture-proof containers to ensure stability during transit. Shipments are dispatched via reliable carriers, with temperature control and hazard compliance, accompanied by all necessary documentation to support customs clearance. Expedited and tracked delivery is available on request for tablets, injections, capsules, and more.
    Storage Inulae Flos Veterinary Grade API should be stored in a tightly sealed container, protected from light and moisture, at a temperature below 25°C. Keep in a dry, cool, and well-ventilated area away from incompatible substances. Ensure the storage area is secure, clean, and free from pests, and follow all regulatory guidelines for veterinary pharmaceutical ingredients.
    Application of Inulae Flos Veterinary Grade API for Tablets / Injections / Capsules / Powders / Granules / Premix / Solutions

    Applications of Inulae Flos Veterinary Grade API for Tablets / Injections / Capsules / Powders / Granules / Premix / Solutions in Industrial Manufacturing

    Our Inulae Flos Veterinary Grade API supports regulated manufacturing across core veterinary pharmaceutical and functional feed additive sectors. The following industrial applications detail distinct downstream scenarios, each referencing relevant industry compliance, established dosage principles, integration into downstream processes, and real-world finished product formats.

    1. Companion Animal Oral Tablet Manufacturing

    Veterinary pharmaceutical factories use our API as an active component in the mass production of oral tablets for companion animals, especially for anti-inflammatory and respiratory supportive therapy in dogs and cats. Tablet formulations require consistent micronization and homogeneity to meet pharmacopoeia monograph standards. The API is processed within dedicated GMP-compliant rooms, with focus on impurity control and precise dosage banding based on animal weight classes and clinical indication. Quality teams perform in-process mixing validation and content uniformity checks throughout large-batch blending and direct compression stages.

    Industry compliance standards

    • United States Pharmacopeia (USP Veterinary)
    • European Pharmacopoeia (Ph. Eur. 10.0, veterinary section)
    • Veterinary Good Manufacturing Practice (GMP) Regulations (21 CFR 225/226; EU 2019/6)
    • China Veterinary Pharmacopoeia (CVP)

    Typical usage ratio

    • API inclusion at 0.5%–5% w/w, adjusted according to therapeutic animal dosage and tablet size
    • Ratio refined based on target animal species and label claim (mg per kg body weight)

    Downstream process integration

    • Direct addition to granulate blend for wet or dry granulation lines
    • Integrated into batch compounding tanks prior to powder compression
    • Subjected to real-time admixture homogeneity tests pre-tableting
    • In-process sampling for assay during scale-up and commercial batches

    Final product types

    • Chewable tablets for dogs and cats
    • Film-coated veterinary prescription tablets
    • Uncoated bulk tablets for veterinary hospitals
    • Palatable scored tablets for at-home administration

    2. Livestock Injectable Suspension and Solution Preparation

    Major animal health vaccine and pharmaceutical producers utilize the API in the compounding of injectable suspensions or solutions targeting livestock species such as cattle, swine, and sheep. The raw material is solubilized or suspended under strictly controlled aseptic conditions to support animal respiratory tract disease control. Manufacturing adheres to stringent residue and contamination monitoring protocols. The API's particle size profile and solubility directly inform process filtration and sterilization approaches in bulk solution preparation tanks.

    Industry compliance standards

    • VICH GL guidelines for veterinary injectable production
    • United States FDA 21 CFR 514 (New Animal Drugs for Injection)
    • China Ministry of Agriculture Standards for Veterinary Injection Production
    • Good Distribution Practice (GDP) for cold-chain injectable products

    Typical usage ratio

    • 1%–10% w/v in finished injectable solution or suspension, customized for bodyweight and species
    • Adjustment based on pharmacokinetic and pharmacodynamic studies in cattle, pigs, and sheep

    Downstream process integration

    • Dissolved or ultrasonically suspended during solution compounding phase
    • Sterile filtration or microfluidics integration following API addition
    • Batches monitored for particulate and dissolution rate pre-sterile fill
    • QC sampling for endotoxin and microbial contamination prior to vial filling

    Final product types

    • Single-dose or multi-dose ampoules
    • Glass vials for veterinary clinic use
    • Pre-filled syringes for on-farm dosing
    • Sterile injectable suspensions for respiratory care

    3. Functional Feed Premix Additives for Intensive Animal Farming

    Integrated feed mills and animal nutrition manufacturers blend our API into functional premixes formulated for poultry, swine, and ruminant sectors. The premix supports animal growth and respiratory health, especially under high-density production conditions. Inclusion occurs in pre-mix lines compliant with feed additive law, prioritizing homogeneity and stability against pelleting/heat processes. The raw material must demonstrate compatibility with other micronutrients and feed supplements in multi-component bulk blending systems.

    Industry compliance standards

    • EU Feed Additives Regulation (Regulation (EC) No 1831/2003)
    • AAFCO (Association of American Feed Control Officials) guidelines
    • China’s Administrative Measures on Feed and Feed Additives (Decree No. 568)
    • ISO 22000 Feed Safety Management System

    Typical usage ratio

    • 50–500 mg API per kg premix, finalized based on recommended dietary allowance and species-specific feed intake
    • Ratio tailored according to feeding phase and farm veterinarian prescription

    Downstream process integration

    • Dosage pre-calculated and pre-weighed for each batch, avoiding feedline cross-contamination
    • Incorporated during dry or semi-dry macro blend phase before microingredient addition
    • Subjected to particle size testing to ensure non-segregation during feed pelleting
    • Batch-controlled using barcode tracking in automated bulk blending systems

    Final product types

    • Poultry functional premixes (starter, grower, finisher blends)
    • Swine high-performance feed premixes
    • Dairy/ruminant vitamin-mineral additive premixes
    • Custom premix formulations for breeding and hatchery industry

    4. Soluble Powder Formulations for Large-Scale Livestock Water Medication

    Livestock pharmaceutical companies incorporate the API in quick-dissolving powder products designed for controlled flock or herd administration via drinking water during respiratory infection outbreaks. Powder production lines focus on particle size uniformity, flowability, and hygroscopicity, allowing for precise pump or dosing equipment calibration on large modern farms. The API integrates seamlessly into continuous mixing and high-capacity industrial spray drying or ribbon blending facilities, ensuring consistent dispersion in hard and soft water systems.

    Industry compliance standards

    • GlobalGAP Livestock Certification Requirements (section for medication-in-water)
    • Veterinary Drug Residue Regulation (EU 37/2010)
    • ISO/IEC 17025 accreditation for QC analytical methods
    • China Ministry of Agriculture and Rural Affairs Veterinary GMP for Soluble Powders

    Typical usage ratio

    • 0.1–1.2 g/L drinking water, managed according to animal weight and water consumption rates
    • Fine-tuning per flock/herd size and health program directive

    Downstream process integration

    • API micronized and dry blended during powder premix phase in dehumidified rooms
    • Optional granulation and sieving for dust control and enhanced dispersibility
    • Inline sampling procedures to verify solubility and dissolution within end-user water systems
    • Sealed in multi-layer moisture-resistant sachets for commercial distribution

    Final product types

    • Soluble powder sachets for poultry, swine, and calf respiratory outbreaks
    • Bulk water-soluble packs for intensive livestock operators
    • Measuring scoop jars for animal health professionals
    • Dose-specific sticks for precision automated dosing systems

    5. Granular Veterinary Dosage Manufacturing for On-Farm Dispensers

    Veterinary pharmaceutical processors apply the API in producing uniform veterinary granules for use with automated feeders in commercial animal production. Granulation enhances dosing accuracy and reduces dosage loss during storage and handling. The API is metered into fluidized bed or high-shear granulation equipment under strict temperature and humidity controls, after being harmonized with binding agents and flow enhancers. QC teams validate homogeneity, particle size distribution, and granule dissolution properties for effective field use.

    Industry compliance standards

    • Veterinary Medicines Directorate (VMD, UK) for granule veterinary medicinal products
    • Ph. Eur. monograph on oral granules for veterinary use
    • China Veterinary Drug GMP for Non-Sterile Solid Dosage Forms
    • WHO GMP Guidelines for Veterinary Medicinal Products

    Typical usage ratio

    • API loadings in granule at 0.2%–3% w/w, optimized depending on dispenser size and targeted animal daily intake
    • Fine tuning as per species and treatment duration under veterinary supervision

    Downstream process integration

    • Batch-wise dosage calculation for each run based on granular weight and animal dosing schedule
    • API uniformly dispersed with excipients prior to granulation step
    • Fluid bed drying and final grading by particle size
    • Post-granulation QC for uniformity and stability for up to 24-month shelf-life

    Final product types

    • Feed-compatible granule packs for pigs, poultry, and ruminants
    • Small-dose granules for specialty dosing in breeding operations
    • Refill cartridges for on-site dosing dispensers
    • Bulk packaged veterinary granules for veterinary practice compounders

    6. Veterinary Capsule Filling for Targeted Animal Indications

    Veterinary branded pharmaceutical companies integrate the API into capsule manufacturing for evidence-based animal therapy applications, such as chronic cough and bronchitis management. The API undergoes microencapsulation or co-milling with absorption-modifying excipients, demanding high-precision content uniformity and rigorous moisture control prior to filling. Capsule filling uses automated machinery with real-time in-line weight control and end-capsule batch sampling for dissolution and release testing, ensuring accurate label dosage claims as required by global veterinary drug dossiers.

    Industry compliance standards

    • European Medicines Agency (EMA) Guidelines for veterinary capsule products
    • US FDA Center for Veterinary Medicine (CVM) Guidance for capsule dosage forms
    • China NMPA Veterinary Capsule Registration Regulations
    • Japanese Pharmacopoeia, Veterinary Section, Capsule Formulations

    Typical usage ratio

    • API loadings of 0.3%–2.5% per capsule, calculated by indication and animal body mass
    • Formulation adapted for targeted release, immediate or slow-release as per veterinary clinical protocol

    Downstream process integration

    • Pre-blended API and excipient feedstock supplied to encapsulation lines
    • Capsule fill-weight checked in-line and off-line for every product lot
    • Real-time sampling for dissolution and release profile comparison to reference standards
    • Batches tested and certified for uniformity and content by Pharmacy QC teams

    Final product types

    • Gelatin or HPMC veterinary capsules
    • Oral capsule packs for canine and feline clinics
    • Small-dosage capsules for exotic and small mammal species
    • Prescription veterinary respiratory support capsule lines

    Free Quote

    Competitive Inulae Flos Veterinary Grade API for Tablets / Injections / Capsules / Powders / Granules / Premix / Solutions prices that fit your budget—flexible terms and customized quotes for every order.

    For samples, pricing, or more information, please contact us at +8615365186327 or mail to admin@ascent-chem.com.

    We will respond to you as soon as possible.

    Tel: +8615365186327

    Email: admin@ascent-chem.com

    Get Free Quote of Ascent Petrochem Holdings Co., Limited

    Flexible payment, competitive price, premium service - Inquire now!

    Certification & Compliance
    More Introduction

    Inulae Flos Veterinary Grade API: Designing for Results That Matter

    Getting to the Root — How Experience in Extraction Shapes the Finished API

    Years of refining botanical extraction processes have taught our team that quality starts long before packaging. Inulae Flos, drawn from the dried flower heads of Inula japonica and related species, demands a careful touch. Harvest timing, gentle dehydration, and specific solvent mixtures all factor into the purity and consistency we produce. Years in the field show up in every batch. From the hard-won insight into seasonal variance, to the way we handle raw material, every step leaves its mark on the active pharmaceutical ingredient used in veterinary treatments.

    When we moved from bulk herbs to a refined active ingredient, the priority wasn’t marketing flash—it was reliability for our downstream customers. We listened to formulation chemists frustrated by caking and weak extract, to dose developers trying to meet tight release specs, and we answered with tangible improvements. Our Inulae Flos API reflects years of practical troubleshooting, not just theory. Every time a batch comes off our line, it already matches the physical and chemical properties our partners need for their specific dosage forms.

    What Matters in a Veterinary API— Lessons from the Production Floor

    In veterinary medicine, unpredictable results cost more than money. They break trust with veterinarians and farmers, and at worst, put animal health at risk. We’ve worked alongside teams formulating tablets and powders who chase particle size, color, or extraction ratio—often without certainty that the next delivery matches the last one. Our process rejects that uncertainty. Each stage is documented, validated, and adjusted with practical feedback.

    Batch-to-batch consistency stands at the center of trust between manufacturer and end user. We track moisture, active markers by HPLC, and examine flow properties so each lot works for direct compression of tablets, uniform blending in powders, or dissolution in solutions and premixes. People pursuing regulatory filings know these details matter in practice, not just on paper. The tighter our controls, the easier it gets for product development and quality teams downstream.

    Specifications Shaped by Real-World Use Cases

    Each user—whether they’re designing a granule for cattle or an injectable for companion animals—faces different bottlenecks. We offer Inulae Flos API in several forms to match those needs, tracked under internal lot numbers, and certified by a clear certificate of analysis. Take powder fineness: coarser material may work in a premix, but it clogs fine-tuned capsule machines. Overly fine powders lead to dust loss in open mixers.

    Our standard specification creates an equilibrium: not so coarse as to risk segregation, not so fine as to invite dust. We routinely test for mesh size, density, and tap flow not because guidelines tell us to, but because we’ve heard about downstream headaches with poorly selected grade. Each delivery includes all documentation expected by regulators in major markets. Color variance, too, carries meaning; we train staff to catch shifts that might signal a change in total active content, side compounds, or source plant morphology.

    Clear Chemical Profile, No Unwelcome Surprises

    We commit to a tight specification for active constituent content—not just total extract yield. For galenic dosage forms—tablets, capsules, and powders—the active marker content by HPLC remains our north star. Each batch profile is anchored on this, removing the guesswork for final formulation. Our active ingredient delivers sesquiterpene lactones, flavonoids, and polysaccharides at known concentrations. We’re upfront about our analysis protocols, including how we confirm the absence of pesticide residues and heavy metals, which can derail a regulatory submission.

    Microbial safety represents another layer where experience pays off. We inspect every lot for total aerobic count and specific pathogens. For veterinarians and veterinary pharmaceutical companies, livestock health cannot tolerate variable targets. Analytical work is not an afterthought here; lab data at release matches the numbers you’ll see in your incoming QC.

    Formulating for Tablets, Powders, Granules, and Injections—Working with Our Clients

    API design never stops at production. We track long-term stability, and we store retains so we can consult QC teams if a client ever flags a concern at the end of a shelf life. Our Inulae Flos sets out to be versatile. Clients developing chewable tablets asked for better compressibility without adding more excipients—so we adjusted drying profiles. Powder developers for mass-mix feeds needed better dispersibility, so we micro-milled a dedicated lot. Injectable solutions depend on clarity and solubility; we keep those metrics in sharp focus and work with partners to adjust extraction solvents within regulatory limits.

    Real repairs happen only when you take feedback seriously. Sometimes a batch gets flagged for taste drift or clumping, and that translates directly to hours lost in a production run. We fix these problems by narrowing our moisture limit, and in some seasons, refine our filtration to catch fines. These details might sound arcane—until a client tells us that punch sticking stopped, or inventory loss cut in half. That’s the sort of impact worth talking about.

    How Our Approach Differs from ‘Generic’ Extracts

    Pressure to cut corners in botanical extraction is everywhere. Some producers chase yield, watering down material with maltodextrin, or skipping vital purification steps to hit an attractive price point. Those shortcuts show up later: powder that refuses to flow, actives that degrade too fast, or extraction residue with unknown pharm/tox profiles. We reject these risks by controlling all sourcing, extraction, and finished processing ourselves. Our production lines do not repack or blend outside extracts—a point that matters for traceability during audits.

    There’s no cost-saving worth the risk of animal safety or supply chain turbulence. Our Inulae Flos supplies maintain a stable chemical signature, proven by repeated third-party testing and met with open records for customer review. Additives—when customer protocols request them—are declared and fully characterized. We know who picks our flowers, when they harvest, and what they treat their crops with. Each lot ties back to a full production ledger, and we invite audits, whether for export, local regulatory registration, or independent review.

    Meeting Compliance—Not as a Checkbox but as the Foundation

    Regulations facing veterinary actives keep tightening. Global customers ask tough questions about GMP, GACP, feed additive status, and pesticide rules. We answer with documentation and access: plant identity assured by macroscopic and HPLC fingerprinting, declaration of farming practices, and validation of cleaning methods. We maintain full traceability from field to drum. Our API meets purity standards recognized for animal use—low heavy metals, low microbials, controlled solvent residues. Not all extract-based APIs reach these marks.

    Veterinary formulations often face added scrutiny at the border or at product registration. Each of our lots leaves the plant backed by lab data that stands up to independent review. Sometimes that data takes longer to collect, and we schedule accordingly rather than cut corners. Animal health doesn’t reward shortcuts. Our staff train with regulatory inspectors and develop internal quality milestones that mean fewer recalls, lower site audit risks, and more confidence for customers further downstream.

    Experience with Animal Health Trends and End Market Challenges

    Market shifts affect sourcing, processing, and customer demand. We’ve witnessed trends toward non-antibiotic growth promoters in livestock, and the move away from synthetic additives. Inulae Flos has found favor thanks to its long local pharmacopoeia history, antioxidant action, and brand recognition among end users, but those trends introduce fresh constraints: lower allowable levels of residual solvents, wider requests for analytical support, more scrutiny on allergen status. Our pipeline tracks these regulatory and commercial currents, and we update protocols when significant data emerges on safety or functional markers.

    Sourcing remains central to quality in botanical APIs. Seasonal, geographical, and varietal variation influence both yield and actives. We control for these differences through tighter supplier relationships, on-field visits, and timely harvest contracts. In times of poor crop years, our reserves and contracted growers provide a buffer so we don’t need to substitute lower quality material or source off the spot market. That outlook delivers consistency—not just for us, but for our long-term clients facing their own reputational pressures.

    Technical Partnerships and Customer Support

    Our engagement with customers doesn’t end at shipping. Incoming complaints or formulation queries get investigated by people who have worked with the plant, not just sales staff. Customers working on new animal species or seeking novel delivery forms bring us challenges we study seriously. We maintain reference libraries of analytical results and undertake repeat stability, mixing, or dissolution studies based on real-world client samples.

    Proactive support has uncovered and fixed issues ranging from trace allergen contamination to unexpected changes in taste from raw material batches. Direct communication and a feedback circle with technical teams help us align our internal protocols with real field outcomes. Unlike companies that only sell on paper, we see new product launches through scale-up and postmarket surveillance, providing retained samples, comparative analytical results, and regulatory dossier support as needed.

    Value Beyond Price—What Consistent API Supply Means for Animal Health Companies

    API procurement isn’t just about meeting a spec. Veterinary manufacturers build long product lifecycles, often with smaller lot sizes or highly variable animal weights. Cost overruns from a single unreliable API shipment can snowball in formulations, regulatory, and distribution. Our job is to deliver peace of mind, both in technical paperwork and batch-to-batch repeatability.

    With years spent building audit-ready records, and hands-on experience with the science behind plant-based APIs, our team recognizes where value shows up. Field data, customer feedback, and regulatory no-objection letters matter more than marketing slogans. We keep direct lines open, respond fast to unexpected snags, and adapt—sometimes batch by batch—to the needs of those making finished medicines in a changing world.

    Modeled on Real Veterinary Medicine, Not Generic Human Extracts

    Veterinary pharmaceuticals operate under distinct pressures. Scale, formulation limits, storage needs, and regulatory outlays set animal actives apart from human generics. We do not blend human and veterinary supply chains, nor do we repackage extracts destined for human supplements for veterinary drug use. Instead, our Inulae Flos APIs follow a dedicated protocol, tracked under veterinary recordkeeping, and supported by documentation tailored to animal health authorities.

    This ‘fence’—holding veterinary and human pipelines separate—may sound like extra bureaucracy, but it shields both regulatory reputation and animal safety. Over the years, emergencies from cross-contaminated supply lines have caused recalls—results we have never experienced. Our reputation stands on stubborn adherence to this division. Veterinarians, farmers, and developers seeking animal-health compliant actives recognize the value of a partner who takes these details to heart.

    Conclusion: Enduring Partnerships, Not Just Transactions

    Decades in botanical actives show one lesson above all: reliability breeds lasting business. That means sharing technical details, accepting auditable transparency, and investing in continuous improvement alongside partners. Our Inulae Flos API, produced strictly for veterinary application, reflects accumulated wisdom, hands-on troubleshooting, and an honest commitment to animal health.

    Real-world feedback, coupled with measured innovation—improved extraction, more detailed analytical mapping, and direct customer support—fuel our growth and sharpen our product. For animal health professionals and manufacturers looking for predictability and a partner with deep roots in the process, our Inulae Flos API stands ready, shaped by practice, accountable to science, and open to inspection.

    We keep lines open for detailed technical discussion and thrive on solving actual formulation challenges, not simply filling orders. Our reputation rests not on claims, but on deliverables that veterinarians, formulation chemists, regulatory reviewers, and, ultimately, treated animals, can rely on. In this fast-changing regulatory and animal health landscape, our focus remains: produce APIs of substance, precision, and integrity—batch after batch, year after year.

    Top